Assessing the Burden of Respiratory Syncytial Virus-Related Bronchiolitis in Primary Care and at 15-Day and 6-Month Follow-Up Before Prophylaxis in France: A Test-Negative Study

• 2024

  Log in to bookmark this resource.

  Log in
• Alexis Rybak; Robert Cohen; Mathieu Bangert; Rolf Kramer; Jean-François Delobbe; Patrice Deberdt
PMID: 38900603DOI: https://dx.doi.org/10.1097/INF.0000000000004360

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This study looks at the impact of RSV-related bronchiolitis in young children in France before RSV prevention methods were used. It describes how many children under 2 years old get sick and compares those with RSV to those without. The study found that kids with RSV had more severe symptoms, like fever and trouble eating, and needed more hospital visits. It also highlights the burden on families, as parents often had to miss work to care for their sick child. New vaccines are being recommended to help prevent these illnesses in future seasons.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Antiviral Agents; Bronchiolitis; Child, Preschool; Follow-Up Studies; France; Infant; Infant, Newborn; Primary Health Care; Prospective Studies; Quality of Life; Respiratory Syncytial Virus Infections; Cost of Illness; Immunization Programs; Respiratory Syncytial Virus, Human; Antibodies, Monoclonal, Humanized; Surveys and Questionnaires

Institutions: Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV)

---

More like this

Diarrheal Deaths After the Introduction of Rotavirus Vaccination in 4 Countries 2021 · Universidad de Cartagena, Centers for Disease Control and Prevention (CDC), Universidad de Santiago de Chile, Pan American Health Organization, Universidad Nacional de Colombia Regional Pediatric Disaster Network Guides Statewide Telehealth Initiation During COVID-19 Pandemic 2022 · University of Washington, Seattle Children's Hospital, Western Regional Alliance for Pediatric Emergency Management (WRAP-EM), UCSF Benioff Children's Hospital, King County Medical Society, Washington State Medical Association Assessment of Effectiveness and Impact of Universal Prophylaxis With Nirsevimab for Prevention of Hospitalizations Due to Respiratory Syncytial Virus in Infants. The NIRSE-GAL Study Protocol 2024 · Instituto de Investigación Sanitaria, World Health Organization (WHO), University of Santiago de Compostela, Instituto de Salud Carlos III

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---